Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
ARUP Laboratories, |
RCV000506806 | SCV000602382 | likely pathogenic | not specified | 2017-03-28 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000668926 | SCV001380213 | likely pathogenic | Very long chain acyl-CoA dehydrogenase deficiency | 2019-08-07 | criteria provided, single submitter | clinical testing | This sequence change falls in intron 11 of the ACADVL gene. It does not directly change the encoded amino acid sequence of the ACADVL protein. This variant is present in population databases (rs765390290, ExAC 0.01%). This variant has been observed in an individual affected with very long-chain acyl-CoA dehydrogenase deficiency (PMID: 9973285). ClinVar contains an entry for this variant (Variation ID: 439363). Experimental studies have shown that this variant disrupts mRNA splicing (PMID: 9973285). In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. |
Gene |
RCV001570475 | SCV001794774 | pathogenic | not provided | 2020-09-21 | criteria provided, single submitter | clinical testing | Published functional studies demonstrate c.1183-15 A>G results in severely decreased normal sized VLCAD mRNA and no residual enzyme activity by Northern blot (Andresen et al., 1999); Not observed at a significant frequency in large population cohorts (Lek et al., 2016); This variant is associated with the following publications: (PMID: 32061778, 9973285) |
Counsyl | RCV000668926 | SCV000793604 | uncertain significance | Very long chain acyl-CoA dehydrogenase deficiency | 2017-08-25 | no assertion criteria provided | clinical testing |